Dec 08 2017 Posted: 11:31 GMT

The Medical Independent recently spoke to Prof Michael O’Dwyer about exciting new Irish blood cancer research data to be presented at the upcoming 2017 American Society of Haematology (ASH) Annual Meeting.

BCNI-related research to be presented at the ASH meeting will highlight the relationship of sialic acid and multiple myeloma, as well as clinical trial data on cyclophosphamide and daratumumab to treat the disease. Prof O’Dwyer said it is an exciting time for research in blood cancer in Ireland as a result of advances made by the BCNI. 

To view the Medical Independent article - see here

 

PreviousNext